Christopher Trevino, MD
Neurology · Evanston, ILNPI 1699018614
Payments from drug & device makers
Across 20 payments — averaging $28.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Monteris Medical Corporation$139
- Intuitive Surgical$103
- Eisai Inc.$51
- Inspire Medical Systems, Inc.$33
- Bristol Myers Squibb$31
- Acrotech Biopharma Inc.$27
- plus $183 from 10 others
What the payments were for
- Food & beverage$567100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Monteris Medical Corporation | 2 | $139 |
| Intuitive Surgical | 1 | $103 |
| Eisai Inc. | 3 | $51 |
| Inspire Medical Systems, Inc. | 1 | $33 |
| Bristol Myers Squibb | 2 | $31 |
| Acrotech Biopharma Inc. | 1 | $27 |
| EUSA Pharma (US) LLC | 1 | $24 |
| Merck | 1 | $22 |
| Bayer | 1 | $21 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $20 |
| Novartis | 1 | $19 |
| Sun Pharmaceutical Industries Inc. | 1 | $17 |
| G1 Therapeutics, Inc. | 1 | $16 |
| Clovis Oncology, Inc. | 1 | $15 |
| Coherus Oncology, Inc. | 1 | $15 |
| Amgen | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$567 in reported general payments places this provider in the 45th percentile of 790 neurology providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VerzenioAbemaciclib | 11 | $151,694 |
| Levetiracetam | 77 | $1,884 |
| Lacosamide | 17 | $1,765 |
| Dexamethasone | 93 | $1,638 |
| Doxycycline Hyclate | 14 | $677 |
| Gabapentin | 26 | $343 |
| Ondansetron Hcl | 24 | $343 |
| Omeprazole | 32 | $338 |
| Nortriptyline Hcl | 11 | $206 |
| Clonazepam | 15 | $165 |
| Lamotrigine | 11 | $137 |
| Memantine Hcl | 18 | $133 |
| Lorazepam | 17 | $14 |
Paid to pharmacies, not to this prescriber.
Other neurology in Evanston
- Afif HentatiEvanston$681K
- James VociEvanston$345K
- Daniel WynnNorthbrook$13.9M
- Concetta ForchettiElk Grove Village$8.5M
- Tatyana SimuniChicago$3.5M
- Danny BegaChicago$2.8M
- Thomas AlaSpringfield$2.4M
- Augusto MiravalleChicago$2.1M
- Leonard Verhagen MetmanChicago$1.8M
- Anthony RederBurr Ridge$1.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.